The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research Group. Diabetes, 1986; 35:530–545.
2.
Diabetes Research in Children Network (DirecNet) Study Group:. Eight-point glucose testing versus the continuous glucose monitoring system in evaluation of glycemic control in type 1 diabetes. J Clin Endocrinol Metab, 2005; 90:3387–3391.
3.
BattelinoT, PhillipM, BratinaN, NimriR, OskarssonP, BolinderJ. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care, 2011; 34:795–800.
4.
The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group:. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care, 2009; 32:1378–1383.
5.
www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM259305.pdf. 2012 November 9.
6.
KovatchevB, AndersonS, HeinemannL, ClarkeW. Comparison of the numerical and clinical accuracy of four continuous glucose monitors. Diabetes Care, 2008; 31:1160–1164.
7.
BeckRW, CalhounP, KollmanC. Use of continuous glucose monitoring as an outcome measure in clinical trials. Diabetes Technol Ther, 2012; 14:877–882.
8.
HovorkaR, NodaleM, HaidarA, WilinskaME. Assessing performance of closed-loop insulin delivery systems by continuous glucose monitoring: drawbacks and way forward. Diabetes Technol Ther, 2013; 15:4–12.
